Life Unit, developing strategies to combat biofilms implicated in drug resistance and CF, becomes newest tenant at CNYBAC

Life Unit LLC, a winner of a $25,000 matching grant for applied research from the Grants for Growth program of CenterStateCEO, will become the newest tenant/client of our member the Central New York Biotech Accelerator at SUNY Upstate. The matching grant supports a partnership between the startup and the Yan-Yeung Luk Lab at Syracuse University.

Life Unit is a privately held biotechnology company focused on the development of novel therapeutics and chemical agents for treating and controlling biofilms implicated in drug resistance, persistent infections, and health conditions including Cystic Fibrosis (CF) and chronic acne.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s